🇺🇸 FDA

Intelligence · Patent portfolio

Axsome Therapeutics Patents

Full USPTO pharma patent portfolio for Axsome Therapeutics — grant dates, expiration, and drug cross-links.

Patents
162
Expiring ≤24m
0

Quick answer

Axsome Therapeutics has 162 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

Page 4 of 4

  1. US 10471068

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Nov 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 10471014

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Nov 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 10463736

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Oct 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 10456471

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Oct 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 10426839

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Sep 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 10369224

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Aug 01 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 10369225

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Aug 01 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 10363312

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 10322181

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Jun 13 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 10307484

    Pharmaceutical compositions comprising meloxicam

    Expires Mon May 30 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 10265400

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 10265324

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 10265399

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 10195279

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Jan 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 10195278

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Jan 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 10137131

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Nov 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 10058614

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Aug 23 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 9821075

    Pharmaceutical compositions comprising meloxicam

    Expires Mon Nov 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Axsome Therapeutics have?

162 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Axsome Therapeutics patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.